Author Question: Identify the chiral center in the product from this experiment. Is the product optically active? ... (Read 96 times)

MGLQZ

  • Hero Member
  • *****
  • Posts: 579
Identify the chiral center in the product from this experiment. Is the product optically active? Explain your answer.

Question 2

Examine the mechanism and the intermediates in the reaction to explain why the thiamine-catalyzed synthesis of benzoin is sensitive to electron-withdrawing and electron-donating substituents in the four position (the para position) of the benzene ring of the aldehyde. For each of the steps in the mechanism, indicate whether electrondonating or electron-withdrawing substituents stabilize the intermediate.



kristenb95

  • Sr. Member
  • ****
  • Posts: 318
Answer to Question 1



The stereocenter has been labeled with an asterisk. None of the starting materials or the catalyst are chiral, so the product will not be optically active. There is no means of generating optical activity when there is none to begin with.

Answer to Question 2




Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question


 

Did you know?

There are actually 60 minerals, 16 vitamins, 12 essential amino acids, and three essential fatty acids that your body needs every day.

Did you know?

The modern decimal position system was the invention of the Hindus (around 800 AD), involving the placing of numerals to indicate their value (units, tens, hundreds, and so on).

Did you know?

Certain topical medications such as clotrimazole and betamethasone are not approved for use in children younger than 12 years of age. They must be used very cautiously, as directed by a doctor, to treat any child. Children have a much greater response to topical steroid medications.

Did you know?

Approximately one in four people diagnosed with diabetes will develop foot problems. Of these, about one-third will require lower extremity amputation.

Did you know?

Most strokes are caused when blood clots move to a blood vessel in the brain and block blood flow to that area. Thrombolytic therapy can be used to dissolve the clot quickly. If given within 3 hours of the first stroke symptoms, this therapy can help limit stroke damage and disability.

For a complete list of videos, visit our video library